New pill could replace shots for prostate cancer treatment
NCT ID NCT02972060
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 37 times
Summary
This study compares an experimental oral drug, darolutamide, to standard hormone therapy (injections) for men with prostate cancer that still responds to hormones. About 250 men with early-stage or limited metastatic disease will be randomly assigned to one of the two treatments. The main goal is to see if the pill can lower PSA levels as effectively as the injections after 24 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Azienda Ospedaliera Citta della Salute e della Scienza di Torino - Ospedale Molinette
Torino, 10126, Italy
-
CHU Dinant Godinne - UCL Namur
Yvoir, 5530, Belgium
-
CHU de Dijon - Centre Georges-Francois-Leclerc
Dijon, 21079, France
-
Cliniques Universitaires Saint-Luc
Brussels, 1200, Belgium
-
Fundacion Instituto Valenciano De Oncologia
Valencia, 46009, Spain
-
Gustave Roussy
Villejuif, 94805, France
-
Hopitaux Universitaires Bordet-Erasme - Hopital Universitaire Erasme
Brussels, 1070, Belgium
-
Hospital Universitario Ramon y Cajal
Madrid, 28034, Spain
-
Hospital Universitario Virgen De La Victoria
Málaga, 29010, Spain
-
Hospital Universitario de Salamanca
Salamanca, 37007, Spain
-
Institut Catala d'Oncologia - ICO Badalona - Hospital Germans Trias i Pujol
Badalona, 08916, Spain
-
Universitair Ziekenhuis Gent
Ghent, 9000, Belgium
Conditions
Explore the condition pages connected to this study.